Home
Mark Elliott Boulding, Exec. Vp and Clo: PTC Therapeutics PTCT Sell · Filed 02/19
Trade details
- Type
- Insider sale
- Amount
- $213,698.16
- Shares · price
- 3,081 sh · $69.36 a share
- Held after
- 108,231 sh
- Trade date
- 26/02/18
- Filed
- 26/02/19
- Days to filing
- 1 days
Sold 2.8% of holdings
- Share of holding sold
- 2.8%
PTC Therapeutics trades, last 26 weeks
What else happened in PTC Therapeutics around then
Filed or reported within 30 days of the trade day · 01/19~03/20Mark Elliott Boulding's recent trades
- Mark Elliott Boulding
Planned sale10b5-1 planPTC Therapeutics
Planned sale10b5-1 planPTC Therapeutics
PTCT
$201.7K
2,813 sh
$201.7K
Filed 08/17
Traded 08/17
- Mark Elliott Boulding
Planned sale10b5-1 planPTC Therapeutics
Planned sale10b5-1 planPTC Therapeutics
PTCT
$427.3K
5,079 sh
$427.3K
Filed 07/06
Traded 07/06
- Mark Elliott Boulding
Sell10b5-1 planPTC Therapeutics
Sell10b5-1 planPTC Therapeutics
PTCT
$518.1K
6,600 sh
$518.1K
Filed 06/22
Traded 06/17
- Mark Elliott Boulding
Sell10b5-1 planPTC Therapeutics
Sell10b5-1 planPTC Therapeutics
PTCT
$146.6K
1,850 sh
$146.6K
Filed 06/22
Traded 06/17
- Mark Elliott Boulding
Sell10b5-1 planPTC Therapeutics
Sell10b5-1 planPTC Therapeutics
PTCT
$133.7K
1,703 sh
$133.7K
Filed 06/22
Traded 06/17